Twist Bioscience Corporation (TWST) Return on equity 2019–2025
Twist Bioscience Corporation (TWST) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-16.4%FY2025 · since FY2019: -70.8% → -16.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -16.4% | +27.7 pp |
| FY2024 | -44.2% | -11.3 pp |
| FY2023 | -32.8% | -5.2 pp |
| FY2022 | -27.6% | -1.4 pp |
| FY2021 | -26.2% | +15.4 pp |
| FY2020 | -41.6% | +29.2 pp |
| FY2019 | -70.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice